Cargando…

Stereochemical preference toward oncotarget: Design, synthesis and in vitro anticancer evaluation of diastereomeric β-lactams

PURPOSE: In the battle against cancer discovery of new and novel chemotherapeutic agent demands extreme obligation. Development of anticancer compounds with higher potency and reduced side-effects is timely and challenging. EXPERIMENTAL DESIGN: A small series of fourteen diastereomeric β-lactams (se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olazarán-Santibáñez, Fabián, Bandyopadhyay, Debasish, Carranza-Rosales, Pilar, Rivera, Gildardo, Balderas-Rentería, Isaías
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514948/ https://www.ncbi.nlm.nih.gov/pubmed/28562328 http://dx.doi.org/10.18632/oncotarget.18077

Ejemplares similares

Remarkable Iodine-Catalyzed Synthesis of Novel Pyrrole- Bearing N‑Polyaromatic β-Lactams
por: Bandyopadhyay, Debasish, et al.
Publicado: (2010)

Dynamic Diastereomerism on Chiral Surfaces
por: Matysik, Sabine C., et al.
Publicado: (2022)

Introducing, OncoTarget
Publicado: (2010)

Hexokinase 2 as oncotarget
por: Patra, Krushna C., et al.
Publicado: (2013)

Deubiquitinating enzymes as oncotargets
por: McClurg, Urszula L., et al.
Publicado: (2015)

MKK3 as oncotarget
por: Bossi, Gianluca
Publicado: (2016)

Akt-Girdin as oncotarget
por: Takahashi, Masahide, et al.
Publicado: (2015)

Eph receptors as oncotargets
por: Charmsaz, Sara, et al.
Publicado: (2017)

Glutathione peroxidases as oncotargets
por: Jiao, Yang, et al.
Publicado: (2017)

Application of 2D EXSY and qNMR Spectroscopy for Diastereomeric Excess Determination Following Chiral Resolution of β‐Lactams
por: McLoughlin, Eavan C., et al.
Publicado: (2022)

YAP as oncotarget in uveal melanoma
por: Yu, Fa-Xing, et al.
Publicado: (2014)

Potential Mechanism of Action of meso-Dihydroguaiaretic Acid on Mycobacterium tuberculosis H37Rv
por: Clemente-Soto, Aldo F., et al.
Publicado: (2014)

Antioxidant and Antiproliferative Activity of the Ethanolic Extract of Equisetum myriochaetum and Molecular Docking of Its Main Metabolites (Apigenin, Kaempferol, and Quercetin) on β-Tubulin
por: Olazarán-Santibañez, Fabián, et al.
Publicado: (2021)

Editorial: Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
por: Rivera, Gildardo, et al.
Publicado: (2021)

Protective effects of phenolic acids on mercury-induced DNA damage in precision-cut kidney slices
por: Carranza-Torres, Irma Edith, et al.
Publicado: (2019)

NMR and EPR Study of Homolysis of Diastereomeric Alkoxyamines
por: Cherkasov, Sergey, et al.
Publicado: (2020)

Self-Sorting in Diastereomeric Mixtures of Functionalized Dipeptides
por: Guan, Qingwen, et al.
Publicado: (2023)

Galectin-1 as an oncotarget in gliomas and melanomas
por: Lefranc, Florence, et al.
Publicado: (2011)

Invasive leader cells: metastatic oncotarget
por: Cheung, Kevin J., et al.
Publicado: (2014)

IRAK1: oncotarget in MDS and AML
por: Beverly, Levi J., et al.
Publicado: (2014)

Bruton's tyrosine kinase: oncotarget in myeloma
por: Tai, Yu-Tzu, et al.
Publicado: (2012)

DNp73: oncotarget in invasion and metastasis
por: Pützer, Brigitte M.
Publicado: (2013)

AXL is an oncotarget in human colorectal cancer
por: Martinelli, Erika, et al.
Publicado: (2015)

Oncotargeting G proteins: The Hippo in the room
por: Feng, Xiaodong, et al.
Publicado: (2014)

4E-BP1 as an oncotarget
por: She, Qing-Bai
Publicado: (2015)

Librarians against scientists: Oncotarget’s lesson
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Diastereomeric bactericidal effect of Ru(phenanthroline)(2)dipyridophenazine
por: Mårtensson, Anna K. F., et al.
Publicado: (2016)

Molecular Research in Pancreatic Cancer: Small Molecule Inhibitors, Their Mechanistic Pathways and Beyond
por: Shetu, Shaila A., et al.
Publicado: (2023)

Liposomes and nanotechnology in drug development: focus on oncotargets
por: Kozako, Tomohiro, et al.
Publicado: (2012)

P62: An emerging oncotarget for osteolytic metastasis
por: Zhang, Jing, et al.
Publicado: (2016)

The inflammasome: an emerging therapeutic oncotarget for cancer prevention
por: Zhiyu, Wang, et al.
Publicado: (2016)

Addendum: Librarians against scientists: Oncotarget’s lesson
por: Blagosklonny, Mikhail V.
Publicado: (2018)

An integrated approach identifies new oncotargets in melanoma
por: Cecconi, Daniela, et al.
Publicado: (2017)

Neuropeptide G Protein-Coupled Receptors as Oncotargets
por: Moody, Terry W., et al.
Publicado: (2018)

HPV: Immunology lessons from an ancient oncotarget
por: Krishna, Sri, et al.
Publicado: (2019)

An introduction to stereochemical restraints
por: Evans, Philip R.
Publicado: (2007)

A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and Antagonists
por: Chambers, Dana R., et al.
Publicado: (2022)

Nucleophilic Substitution at Tetracoordinate Phosphorus. Stereochemical Course and Mechanisms of Nucleophilic Displacement Reactions at Phosphorus in Diastereomeric cis- and trans-2-Halogeno-4-methyl-1,3,2-dioxaphosphorinan-2-thiones: Experimental and DFT Studies
por: Mikołajczyk, Marian, et al.
Publicado: (2021)

To Fold or Not to Fold: Diastereomeric Optimization of an α-Helical Antimicrobial Peptide
por: Personne, Hippolyte, et al.
Publicado: (2023)

Metformin May Alter the Metabolic Reprogramming in Cancer Cells by Disrupting the L-Arginine Metabolism: A Preliminary Computational Study
por: Espinosa-Rodriguez, Bryan Alejandro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_as4tnp6ghcqn1kndh7kur9kcda